期刊文献+

垂体腺瘤患者血浆神经肽Y与垂体激素水平相关性研究 被引量:8

Research on the relationship between neuropeptide Y and pituitary hormones in plasma of pituitary adenoma patients
原文传递
导出
摘要 目的探讨垂体腺瘤患者血浆神经肽Y(NPY)与垂体激素之间的相关关系。方法收集82例垂体腺瘤患者及20例对照组空腹静脉血3ml,进行血浆NPY放免测定分析,并与垂体激素水平进行相关分析。初步探讨NPY与部分其他临床指标之间的相关性。结果⑴垂体腺瘤患者、泌乳素细胞腺瘤、生长激素细胞腺瘤、无内分泌功能细胞腺瘤及多分泌功能细胞腺瘤组中血浆NPY与PRL呈负相关。⑵垂体腺瘤患者血浆NPY与ACTH呈正相关。⑶促性腺激素细胞腺瘤中NPY与LH呈正相关而与GH呈负相关。⑷NPY在垂体腺瘤组与对照组中血浆含量明显不同,而且部分不同垂体腺瘤组之间也存在明显差异。⑸全组垂体腺瘤手术后血浆NPY的含量下降。结论NPY参与了垂体腺瘤病理生理中下丘脑-垂体轴许多激素的调节,可能与垂体腺瘤的发生有关。 Objective In order to investigate the correlation between neuropeptide Y and pituitary hormones in plasma of pituitary adenoma patients. Methods The 3ml venous blood was collected from 82 patients with pituitary adenoma and 20 normal persons as control in this experiment. The level of NPY in plasma was measured by radio-immunity analysis and the correlation was analyzed between the level of pituitary hormones and NPY in plasma of the patients with pituitary adenoma. In addition, the correlation and difference were discussed elementarily between the NPY and other clinical manifestations. Results (1) There was a negative correlation between the level of PRL and NPY in plasma of the patients with pituitary adenoma, PRL-secreting adenoma, GH-secreting adenoma, nonsecreting pituitary adenoma,polysecreting pituitary adenoma. (2) There was a positive correlation between the level of ACTH and NPY in plasma of the patients with pituitary adenoma. (3) There was a positive correlation between the level of LH and NPY in plasma of the patients with ACTH-secreting adenoma, however, there was a negtive correlation between the level of GH and NPY in this adenoma. (4) It was shown that there was distinctive difference of the level of NPY between the group of pituitary adenoma and the control and in the different types of hypophysoma. (5) It was found that there was distinctive difference of the level of NPY between pre and pro of operation. Conclusions NPY is involved in the regulation of hypothalami-pituitary hormones and the pathology of pituitary adenoma.
出处 《中华神经外科杂志》 CSCD 北大核心 2005年第10期612-615,共4页 Chinese Journal of Neurosurgery
基金 国家自然科学基金项目(项目编号:30471772)
  • 相关文献

参考文献12

  • 1Tatemoto K, Carlquist M, Mutt V.Neuropeptide y a novel brain peptide with structural similarties to peptide YY and pancreatic polypeptide. Nature, 1982, 296: 659-660.
  • 2Larsen PJ, Jukes KE, Chowdrey HS,et al. Neuropeptide-Y potentiates the secretion of vasopressin from the neurointermediate lobe of the rat pituitary gland. Endocrinology, 1994, 134: 1635-1639.
  • 3Clarke IJ, Pompolo S, Scott CJ, et al. Cells of the arcuate nucleus and ventromedial nucleus of the ovariectomized ewe that respond to oestrogen: A study using fos immunohistochemistry.J Neuroendocrinology, 2001, 13: 934-941.
  • 4Gmuzmann E, Deruaz JP, Gomez F, et al. Immunolocalization of neuropeptide y in human pituitary tumours. Regul Pept,1998, 25: 75-92.
  • 5Knerr I, Schuster S, Nomikos P,et al.Gene expression of adrenomedullin, leptin, their receptors and non functioning pituitary adenomas, meningiomas and malignant intrucranial tumors in humans. Neuropathology and Applied Neurobiology,2001, 27: 215-222.
  • 6郭长利 马景镒.人体血浆和垂体肿瘤组织神经肽Y含量及其mRNA表达[J].河北医药,2000,22:14-14.
  • 7郭常利,马景鑑,杨树源,孙银水,孙柏山,韩玉昆.人体血浆和垂体腺瘤组织中的神经肽Y含量及其临床意义[J].中国临床神经科学,2001,9(2):148-150. 被引量:4
  • 8Peng XD, Park S, Gadelha MR, et al. The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice:hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback. Endocrinology,2001. 142: 1117-1123.
  • 9Tamas LH, Shuye P, Michael GD, et al. A GABA-neuropeptide y (NPY) in LH release. Peptides, 2001, 22: 473-481.
  • 10Sainsbury A, Herzog H. Inhibitory effects of central neuropeptde y on the somatotropic and gonadotropic axes in male rates are independent of adrenal hormones. Peptides, 2001, 22: 467-471.

二级参考文献8

  • 1[1]Jones PM, Ghatei MA, Wallis SC, et al. Differential response ofneuropeptide Y, SP and VIP in the rat anterior pituitary gland to alterations inthyroid hormone status. J Endocrinol, 1994; 143: 393-397
  • 2[2]Byme JM, Jones PM, HIll SF, et al. Expression of messenger ribonucleicacids encoding neuropeptide-Y, substance-P, and vasoactive intestinalpolypeptide in human pituitary. J Clin endocrinol Metab, 1992; 75:983-987
  • 3[3]Adams EF, Venetikou Ms, Woods CA, et al. Neuropeptide Y directly inhibitsgrowth hormone secretion by human pituitary somatotropic tumours. ActaEndocrinol (Copenh), 1987; 115:149-154
  • 4[4]Watanobe H, Tamura T. Stimulation by neuropentide Y of growth hormonesecretion in prolactinoma in vivo. Neuropeptides, 1996; 30:429-432
  • 5[5]Watanobe H, Tamura T. Stimulatory and inhibitory effects of neuropeptide Yon growth hormone secretion in acromegaly in vivo. Neuropeptides, 1997;31:29-34
  • 6[6]Grouzmann E, Deruaz JP, Gomez F, et al. lmmunolocalization ofneuropeptide Y in human pituitay tumours. Regul Pept, 1998; 25(75-76):89-92
  • 7[7]Chabot JG, Enjalbert A, Pelletier G, et al. Evidence for a direct action ofneuropeptide Y in the rat pituitary gland. Neuroendocrinology, 1988; 47:511-517
  • 8[8]Allen JM, Yeats JC, Causon R, et al. Neuropeptide and its flanking peptidein human endocrine tumors and plasma. J Clin Endocrin Metab, 1987; 64:1199-1204

共引文献3

同被引文献58

引证文献8

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部